NCT02279537View on ClinicalTrials.gov

Real Life of Aflibercept In FraNce: oBservatiOnnal Study in Wet AMD

CompletedOBSERVATIONAL

Enrollment

593

Participants

Timeline

Start Date

January 2, 2014

Primary Completion Date

April 17, 2019

Study Completion Date

April 17, 2019

Conditions

Wet Macular Degeneration

Interventions

DRUG

Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)

Administration by intravitreal injection

Trial Locations (1)

Unknown

Multiple Locations

Sponsors

Lead Sponsor

All Listed Sponsors

collaborator

Regeneron Pharmaceuticals

INDUSTRY

lead

Bayer

INDUSTRY